Prior to acquisition, our BD&L client sought strategic guidance to support deal negotiations for an asset in the cardiovascular space. Once in house, the client’s multi-disciplinary team needed to develop the commercial strategy across all stakeholder groups in key markets (US, EU4, and emerging markets).

With comprehensive analysis, in-depth qualitative and quantitative market research, scenario planning activities, workshop series facilitation, and forecast development, Acsel delivered multiple engagements including:

• Opportunity Assessment: Analysis of market and asset dynamics to determine revenue potential for the acquisition candidate
• Payer Assessment: Evaluation of payers expected management, pricing considerations, and value generation requirements
• Global HCP Perspective Research: Interviews with several specialist types to understand treatment dynamics, determine treatment criticality, and define preference share
• Global Patient Journey: Detailed mapping of intervention points across the patient experience from identification to treatment to support commercial strategy and forecast refinement
• Global Pricing and Access Strategy: Determination of pricing, coverage, and evidence generation requirements on a scenario basis to enable access decision making
• Emerging Markets Landscape: Assessment of overall patient journey and competitive landscape dynamics within key emerging markets to determine commercial viability
  

Throughout the nearly five-year partnership, the Acsel team guided client decision-making on key strategic milestones, including asset acquisition, clinical development program design, and revenue maximizing commercial strategy.